Phase 3 Osteoarthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with osteoarthritis (a type of joint wear and tear) affecting the finger joints, confirmed using X-rays taken within the last 6 months and matching reported symptoms.
- People aged 16 years or older.
- People who have hand pain rated above 40 out of 100 on a pain scale.
- People who have already tried at least one standard pain medication (such as anti-inflammatory gels or tablets, not including paracetamol) and found it did not work well enough.
Who may not be able to join:
- People who have a chronic inflammatory or rheumatic disease (such as rheumatoid arthritis).
- People who currently have an infectious disease.
- People with a known diagnosis of osteoporosis (brittle bones).
- People with a known diagnosis of diabetes.
- People who have previously been diagnosed with fibromyalgia (a widespread pain condition).
- People with a known diagnosis of myasthenia gravis (a muscle weakness condition).
- People who have previously had surgery on their hand (for example, carpal tunnel surgery).
- People whose other medications are flagged as interacting with the study drug by the Dutch Medication Surveillance System (confirm with trial site).
- People who currently have a stomach or duodenal ulcer.
- People who currently have an active infection.
- People with liver cirrhosis (serious liver scarring).
- People who are pregnant or breastfeeding.
- People who are known to not respond to, or cannot tolerate, the study drug methylprednisolone.
- People who are not able to read or write in Dutch.
- People who have a diagnosis of epilepsy.
- People considered to be at risk of a psychiatric disorder (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0243659276
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Efficacy of intramuscular methylprednisolone acetate in reducing hand pain between baseline and week 4, compared to placebo measured on a 0-100 mm Visual Analogue Scale
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.